Daewoong pharmaceutical Co.,Ltd (069620.KS) KSC

123,000.00

-4200(-3.30%)

Updated at June 02 03:30PM

Currency In KRW

Valuation

Market Cap2T
Enterprise Value2.66T
P/E Ratio7.13
PEG Ratio0.02
Price/Sales Ratio0.89
Price/Book Ratio1.39
Enterprise/Revenue1.35
Enterprise/EBITDA9.24

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.13
Operating Margin0.11

Management Effectiveness

Return On Assets0.08
Return On Equity0.21

Income Statement

Revenue1.57T
Revenue/Share137,412.12
Gross Profit812.85B
EBITDA245.78B
Net Income195.86B
Diluted EPS17,021

Balance Sheet

Total Cash168.03B
Total Cash/Share14,501.66
Total Debt900.43B
Total Debt/Equity0.88
Current Ratio1.12
Book Value Per Share99,613.57

Price History

52-Week Change-27
52-Week High199,400
52-Week Low122,000
Moving Average 50 Days147,398
Moving Average 200 Days155,648

Statistics

Average Volume32,011
Shares Outstanding11.51M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate600
Trailing Annual Dividend Yield0.49
Payout Ratio0.05
Last Split Factor103:100
Last Split DateDecember 27, 2012